Safety and efficacy of intravenousdiltiazem in atrial fibrillation or atrial flutter
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier
- Vol. 75 (1) , 45-49
- https://doi.org/10.1016/s0002-9149(99)80525-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazemThe American Journal of Cardiology, 1992
- A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter studyJournal of the American College of Cardiology, 1991
- Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failureThe American Journal of Cardiology, 1991
- Different cardiodepressant potency of various calcium antagonists in human myocardiumThe American Journal of Cardiology, 1990
- Hemodynamic, electrocardiographic, and cellular effects of diltiazem treatment after cardiac arrest and resuscitationJournal of Critical Care, 1989
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter studyJournal of the American College of Cardiology, 1989
- Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.Circulation, 1983
- Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: A reviewThe American Journal of Cardiology, 1982
- Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart diseaseThe American Journal of Cardiology, 1981